ATE359810T1 - Faktor aus pigmentiertem epithel (pedf) charakterisierung, genomische organisation und sequenz des pedf gens - Google Patents

Faktor aus pigmentiertem epithel (pedf) charakterisierung, genomische organisation und sequenz des pedf gens

Info

Publication number
ATE359810T1
ATE359810T1 AT95922988T AT95922988T ATE359810T1 AT E359810 T1 ATE359810 T1 AT E359810T1 AT 95922988 T AT95922988 T AT 95922988T AT 95922988 T AT95922988 T AT 95922988T AT E359810 T1 ATE359810 T1 AT E359810T1
Authority
AT
Austria
Prior art keywords
pedf
rpedf
characterization
sequence
effect
Prior art date
Application number
AT95922988T
Other languages
English (en)
Inventor
Gerald J Chader
Sofia Patricia Becerra
Joan P Schwartz
Takayuki Taniwaki
Original Assignee
Us Gov Health & Human Serv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/257,963 external-priority patent/US5840686A/en
Application filed by Us Gov Health & Human Serv filed Critical Us Gov Health & Human Serv
Application granted granted Critical
Publication of ATE359810T1 publication Critical patent/ATE359810T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/38—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against protease inhibitors of peptide structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Information Retrieval, Db Structures And Fs Structures Therefor (AREA)
AT95922988T 1994-06-07 1995-06-06 Faktor aus pigmentiertem epithel (pedf) charakterisierung, genomische organisation und sequenz des pedf gens ATE359810T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/257,963 US5840686A (en) 1992-09-24 1994-06-07 Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use
US08/367,841 US6319687B1 (en) 1992-09-24 1994-12-30 Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene

Publications (1)

Publication Number Publication Date
ATE359810T1 true ATE359810T1 (de) 2007-05-15

Family

ID=26946312

Family Applications (2)

Application Number Title Priority Date Filing Date
AT07007638T ATE451118T1 (de) 1994-06-07 1995-06-06 Von pigmentepithel stammender faktor zur hemmug der glialzellen-proliferation
AT95922988T ATE359810T1 (de) 1994-06-07 1995-06-06 Faktor aus pigmentiertem epithel (pedf) charakterisierung, genomische organisation und sequenz des pedf gens

Family Applications Before (1)

Application Number Title Priority Date Filing Date
AT07007638T ATE451118T1 (de) 1994-06-07 1995-06-06 Von pigmentepithel stammender faktor zur hemmug der glialzellen-proliferation

Country Status (9)

Country Link
US (3) US6319687B1 (de)
EP (2) EP0765169B1 (de)
JP (3) JPH10504705A (de)
AT (2) ATE451118T1 (de)
AU (1) AU710141B2 (de)
CA (2) CA2190365C (de)
DE (2) DE69536028D1 (de)
ES (1) ES2288300T3 (de)
WO (1) WO1995033480A1 (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5976790A (en) 1992-03-04 1999-11-02 The Regents Of The University Of California Comparative Genomic Hybridization (CGH)
US6319687B1 (en) * 1992-09-24 2001-11-20 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US7049424B2 (en) 1996-07-15 2006-05-23 The Regents Of The University Of California Genes from the 20Q13 amplicon and their uses
US5801021A (en) 1995-10-20 1998-09-01 The Regents Of The University Of California Amplifications of chromosomal region 20q13 as a prognostic indicator in breast cancer
US7455964B1 (en) 1996-07-15 2008-11-25 The Hospital For Sick Children Genes from the 20q13 amplicon and their uses
WO1998024812A2 (en) * 1996-12-03 1998-06-11 Neurocrine Biosciences, Inc. A6la5a12 polypeptides and polynucleotides and methods of use therefor
AU5620598A (en) 1996-12-31 1998-07-31 Antioxidant Pharmaceuticals Corporation Pharmaceutical preparations of glutathione and methods of administration thereof
US7105496B2 (en) 1998-07-23 2006-09-12 Northwestern University Methods and compositions for inhibiting angiogenesis
US6797691B1 (en) 1997-07-23 2004-09-28 Northwestern University Methods and compositions for inhibiting angiogenesis
WO1999004806A1 (en) 1997-07-23 1999-02-04 Northwestern University Methods and compositions for inhibiting angiogenesis
US6399349B1 (en) * 1997-09-02 2002-06-04 James W. Ryan Human aminopeptidase P gene
WO2000058336A1 (en) * 1999-03-26 2000-10-05 Human Genome Sciences, Inc. 50 human secreted proteins
EP1187931A4 (de) * 1999-06-11 2003-11-12 Human Genome Sciences Inc 49 humane sekretierte proteine
WO2001058494A2 (en) * 2000-02-11 2001-08-16 Genvec, Inc. Gene therapy for treating ocular-related disorders
US6821775B1 (en) 2000-02-11 2004-11-23 Genvec, Inc. Viral vector encoding pigment epithelium-derived factor
DE60136444D1 (de) * 2000-02-23 2008-12-18 Univ Northwestern Pharmazeutische zusammensetzung zur angiogenese-hemmung mittels eines pedf-fragmentes
AU2001237543A1 (en) * 2000-02-24 2001-09-03 Oxford Glycosciences (Uk) Ltd. Proteins, genes and their use for diagnosis and treatment of schizophrenia
IL147444A0 (en) * 2002-01-03 2002-08-14 Yeda Res & Dev Process for the production of pigment epithelium derived factor (pedf) from human blood and uses thereof
US20030158112A1 (en) 2002-02-15 2003-08-21 Johns Hopkins University School Of Medicine Selective induction of apoptosis to treat ocular disease
WO2004007749A2 (en) * 2002-07-12 2004-01-22 University Of Washington Methods and systems for extended in vitro culture of neuronal cells
US20040161423A1 (en) * 2002-07-18 2004-08-19 Sanjeev Kumar (Mendiratta) Polymer modified anti-angiogenic serpins
US20050222031A1 (en) * 2004-03-19 2005-10-06 Yamagishi Sho-Ichi Method for preventing or treating malignant melanoma
WO2006046584A1 (ja) * 2004-10-26 2006-05-04 Santen Pharmaceutical Co., Ltd. 視細胞障害治療剤
WO2006054278A2 (en) * 2004-11-16 2006-05-26 Yeda Research And Development Co. Ltd. At The Weizmann Institute Of Science Variants of pigment epithelium derived factor and uses thereof
EP1869075B1 (de) * 2005-02-28 2012-04-11 Sangamo BioSciences, Inc. Antiangiogene methoden und zusammensetzungen
GB0516058D0 (en) * 2005-08-04 2005-09-14 Oxford Genome Sciences Uk Ltd New protein isoforms and uses thereof
CA2629519A1 (en) 2005-11-14 2007-05-18 Yeda Research & Development Co. Ltd. At The Weizmann Institute Of Scienc E Improved variants of pigment epithelium derived factor and uses thereof
WO2007095350A2 (en) * 2006-02-15 2007-08-23 Yale University Compositions and methods for use of pigment epithelial derived factor (pedf) peptide fragments
ITTV20080039A1 (it) * 2008-03-06 2009-09-07 Alpinestars Research Srl Collare di protezione in particolare per guidatori di motoveicoli
CA2776748A1 (en) * 2009-10-08 2011-04-14 Neurotech Usa, Inc. Use of pedf in an encapsulated cell-based delivery system
US9938328B2 (en) * 2012-09-17 2018-04-10 Mackay Memorial Hospital Use of PEDF-derived polypeptides for treating alopecia and/or hair depigmentation
US9611314B2 (en) 2013-09-13 2017-04-04 The Penn State Research Foundation Functional peptide analogs of PEDF
JP6522063B2 (ja) * 2017-08-10 2019-05-29 マクカイ メモリアル ホスピタル 脱毛症及び／又は毛髪色素脱失を治療するためのｐｅｄｆ由来のポリペプチドの使用
KR101998155B1 (ko) * 2017-09-22 2019-07-10 (주)케어젠 혈관신생 억제용 펩타이드 및 이의 용도

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1700691A (en) 1927-03-08 1929-01-29 Lilly Co Eli Optic-nerve and retina extract and process of making it
FR2461002A1 (fr) 1979-07-13 1981-01-30 Inst Nat Sante Rech Med Procede pour stimuler la croissance des cellules d'epiderme humain et produits faisant application dudit procede
US4477435A (en) 1981-05-19 1984-10-16 Institut National De La Sante Et De La Recherche Medicale (Inserm) Method for regenerating corneal epithelium
US4534967A (en) 1982-08-03 1985-08-13 Boston Biomedical Research Institute Cell proliferation inhibitor and method of preparation
US4770877A (en) 1982-08-03 1988-09-13 Boston Biomedical Research Institute Isolation of a high molecular weight aortic endothelial cell growth inhibitor
US4818542A (en) * 1983-11-14 1989-04-04 The University Of Kentucky Research Foundation Porous microspheres for drug delivery and methods for making same
WO1986004783A1 (en) 1985-02-26 1986-08-28 Glaser Bert M Neovascularization inhibitors and methods for their production and use
US5244902A (en) * 1989-08-21 1993-09-14 Beth Israel Hospital Association Topical application of spiperone or derivatives thereof for treatment of pathological conditions associated with immune responses
DE69333229T2 (de) * 1992-06-04 2004-08-12 University Of Southern California, Los Angeles Verfahren zur reinigung eines neurotrophen faktors aus pigmentiertem retinalen epithelgewebe
US5840686A (en) * 1992-09-24 1998-11-24 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization of its novel biological activity and sequences encoding and expressing the protein and methods of use
US6451763B1 (en) * 1992-06-04 2002-09-17 The United States Of America As Represented By The Department Of Health And Human Services Retinal pigmented epithelium derived neurotrophic factor and methods of use
US6319687B1 (en) * 1992-09-24 2001-11-20 The United States Of America As Represented By The Department Of Health And Human Services Pigment epithelium-derived factor: characterization, genomic organization and sequence of PEDF gene
FI104514B (fi) * 1997-02-18 2000-02-15 Safematic Oy Sovitelma kiertovoitelujärjestelmän yhteydessä
US6319781B1 (en) * 2001-02-28 2001-11-20 Macronix International Co., Ltd. Method of fabricating self-aligned multilevel mask ROM

Also Published As

Publication number Publication date
WO1995033480A1 (en) 1995-12-14
ATE451118T1 (de) 2009-12-15
DE69535467T2 (de) 2008-01-03
JP2009153517A (ja) 2009-07-16
AU2768195A (en) 1996-01-04
JP2006149405A (ja) 2006-06-15
DE69535467D1 (de) 2007-05-31
EP0765169A1 (de) 1997-04-02
EP1864678B1 (de) 2009-12-09
DE69536028D1 (de) 2010-01-21
AU710141B2 (en) 1999-09-16
US7179621B1 (en) 2007-02-20
CA2190365A1 (en) 1995-12-14
US20060008900A1 (en) 2006-01-12
US6319687B1 (en) 2001-11-20
CA2704083C (en) 2013-07-30
CA2190365C (en) 2010-08-03
JPH10504705A (ja) 1998-05-12
CA2704083A1 (en) 1995-12-14
ES2288300T3 (es) 2008-01-01
JP5108797B2 (ja) 2012-12-26
EP1864678A1 (de) 2007-12-12
EP0765169B1 (de) 2007-04-18

Similar Documents

Publication Publication Date Title
DE69535467D1 (de) Faktor aus pigmentiertem epithel (pedf) charakterisierung, genomische organisation und sequenz des pedf gens
EP1637608A3 (de) Rekombinanter Adenoviren-Vektor und Verfahren zur Verwendung
EP1903112A3 (de) Activin-Rezeptoren-ähnliche Kinase, die zur TGF-Rezeptor-Familie und/oder zur BMP-Rezeptor-Familie gehört
EP0614977A3 (en) Huntingtin dna, protein and uses thereof.
ATE318915T1 (de) Genfamilie von apoptose-verwandten peptiden, dadurch kodierte peptide und verfahren zu deren herstellung
CY1111950T1 (el) 32 ανθρωπινες εκκρινομενες πρωτεϊνες
DE69635207D1 (de) Auf Chromosom 1 lokalisiertes Gen dessen Genprodukt mit der Alzheimerschen Krankheit assoziiert ist.
ATE284954T1 (de) Hyaluronan synthase gen und seine verwendung
ATE348164T1 (de) Neuroprotektive eigenschaften von gdf-15, ein mitglied der tgf-beta superfamilie
CA2174971A1 (en) Neural Axon Outgrowth Modulators
EP0963377A4 (de) Interleukin-19.
EP0947583A3 (de) Expressionsaktivierende Nukleinsäurefragmente des Melanom-inhibierenden Proteins (MIA)
DE68918673D1 (de) IgG-bindendes Protein H, kodierendes Gen dafür und Verfahren zu seiner Herstellung.
CA2294566A1 (en) Ikk-.alpha. proteins, nucleic acids and methods
NZ239357A (en) Human mk gene and protein sequence
WO2002074956A3 (en) Dopaminergic neuronal survival-promoting factors and uses thereof
WO2000009693A3 (en) Identification of the gene causing the mouse scurfy phenotype and its human ortholog
CA2245584A1 (en) Recombinant expression of s-layer proteins
DE3584029D1 (de) Expressionsvektoren, dns-fragmente, peptide, wirte und verfahren zur herstellung von peptiden.
DE69739071D1 (de) Menschliche tak1 und für diese kodierende dna
ATE23190T1 (de) Plasmid p svh 1 und seine verwendung.
TW342413B (en) Novel toxins isolated from Bracon Hebetor
HU9503352D0 (en) Plant gene-expression vector family based on dna fragments regulating alfalfa h3 histon gene variant (ms h3g1)
EP1757618A3 (de) Angiogenese-assoziierte proteine und dafür kodierende nukleinsaüre
EP0723016A3 (de) Leukocyten-aktivierender Faktor

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties